We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Alexander Beadle

Science Writer

Contact Us

@alexbeadlesci

Alexander Beadle has been working as a freelance science writer since 2017 and has covered the cannabis industry for Analytical Cannabis since 2018. He has also written for our sister publication, Technology Networks, and the cannabis industry consultant firm Prohibition Partners, among others. Alexander holds an MChem in materials chemistry from the University of St Andrews, where he won a Chemistry Purdie Scholarship and conducted research into zeolite crystal growth mechanisms and the action of single-molecule transistors.

Latest Content From Alexander Beadle

Many CBD Products Still Don’t Contain Advertised Amounts, FDA Study Finds

Product testing conducted by the US Food and Drug Administration (FDA) has found that many CBD-infused products on sale in the United States are mislabeled, containing vastly differing amounts of CBD than advertised on the product packaging.

VIEW

Maine Introduces Emergency Rules to Streamline Cannabis Testing

New sample collectors will be allowed to collect samples of cannabis and cannabis products for testing on behalf of the state’s cannabis testing facilities.

VIEW

Israeli Lawmakers Advance Two Cannabis Legalization Bills

The bills still face several more months of debate before they can become a law, but this latest action still represents a meaningful step forward for cannabis law reform in Israel.

VIEW

UK Medical Cannabis Firm Announces New Import Deal

LYPHE Group announced a new partnership with Eaststone Ltd to secure import, distribution, and other ancillary services relating to the cannabis sector in the United Kingdom.

VIEW

Sapphire Medical Clinics Launches Registry to Expand Medical Cannabis Evidence Base in the UK

The registry aims to collect and analyze clinical information from patients taking medical cannabis treatments in the UK for all recognized eligible conditions.

VIEW

Medical Cannabis Shouldn’t Always Be Considered a Last Resort, Says Review

Written by some of the country’s top drug science and policy researchers, the review puts forward a number of ‘next steps’ for the country to consider pursuing in order to better support prospective medical cannabis patients in the UK.

VIEW

Researchers Believe Cannabinoids Could Treat HIV-associated Disorders

Researchers at George Mason University have received $450,000 in funding from the National Institutes of Health to pursue new research into whether cannabinoids can help treat HIV-associated disorders.

VIEW

French Medical Cannabis Pilot Delayed Until January 2021

Initially scheduled to begin in September, the need to tackle the coronavirus pandemic means that the medical cannabis program will be postponed until January 2021 at the latest.

VIEW

Legal Cannabis Report Calls for More Action on Social Equity

And after compiling and comparing the cannabis-related social equity policies of every US state, the report from Transform Drug Policy Foundation found some regions lacking.

VIEW

Washington State Bans Vitamin E Acetate in Vape Products

The substance is the first compound of its kind to be banned in the US state under the new regulatory powers.

VIEW